← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$10K

Shares

796

Price

$13

Filed

Jun 30

Why this score? (7/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Valantine Hannah

Title

CIK

0001855608

Roles

Director

Transaction Details

Transaction Date

2021-12-28

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,687

Filing Info

Accession No.

0000950170-25-091756

Form Type

4/A

Issuer CIK

0001743881

Valantine Hannah's History

Date Ticker Type Value
2025-11-12 BBIO M $1.2M
2025-11-12 BBIO $1.7M
2025-11-12 BBIO M $0
2025-06-26 BBIO $39K
2025-06-26 BBIO $68K
2025-06-26 BBIO $18K
2025-06-26 BBIO $83K
2025-06-20 BBIO A $0
2025-06-20 BBIO A $0
2025-06-18 CDNA $203K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10